UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended ~~June~~September 30, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 000-53616

Incoming, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 244 5th Avenue, Ste V235

New York, NY 10001
(Address of principal executive offices, including zip code.)

(800) 385-5705
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-Y (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [X] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange Act.

~~Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [ ] Smaller Reporting Company [X]~~1

Large accelerated filer [ ]Accelerated filer [ ]

Non-accelerated filer [ ]Smaller Reporting Company[X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes [ ] No [X]

AsIndicate ofby ~~August~~check ~~14,~~mark ~~2017,~~whether ~~there~~the ~~are~~registrant ~~31,774,332~~is ~~shares~~an emerging growth company as deﬁned in Rule 405 of ~~Class~~the ASecurities ~~common~~Act ~~stock~~of ~~and~~1933 ~~1,980,000~~(§230.405 ~~shares~~of this chapter) or Rule 12b-2 of ~~Class~~the BSecurities ~~common~~Exchange ~~stock~~Act ~~outstanding~~of 1934 (§240.12b-2 of this chapter).

Emerging growth company[ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised ﬁnancial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

As of November 14, 2017, there are 31,774,332 shares of Class A common stock and 1,980,000 shares of Class B common stock outstanding.

All references in this Report on Form 10-Q to the terms “we”, “our”, “us”, the “Company”, “ICNN” and the “Registrant” refer to Incoming, Inc. unless the context indicates another meaning.

ITEM 1. FINANCIAL STATEMENTS

Index to the Unaudited Financial Statements	3
UNAUDITED CONSOLIDATED BALANCE SHEETS	4
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS	5
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS	6
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS	7

ITEM 1. FINANCIAL STATEMENTS

Index to the Unaudited Financial Statements	3

UNAUDITED CONSOLIDATED BALANCE SHEETS	4

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS	5

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS	6

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS	7

Table of Contents

INCOMING, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

		September 30, 2017		December 31, 2016
		(Unaudited)
ASSETS
Current Assets
Cash	$	750	$	11,460
Accounts receivable, trade, net		228		12,046
Inventory		12,023		25,810
Prepaid expenses		6,955		4,851
Other current assets		400		400
Total current assets		20,356		54,567

Property and equipment, net		486,036		549,839
Total Assets	$	506,392	$	604,406


LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current Liabilities
Accounts payable	$	231,884	$	222,773
Accrued liabilities		75,346		69,477
Short-term debt		3,153		2,176
Accounts payable – related parties		276,178		307,332
Related party debt - short-term		73,548		-
Total current liabilities		660,109		601,758

Total Liabilities		660,109		601,758

Capital stock $0.001 par value; 200,000,000 shares authorized
Class A – 31,774,332 shares issued and outstanding, respectively		31,774		31,774
Convertible Class B – 1,980,000 shares issued and outstanding		1,980		1,980
Additional paid in capital		6,482,070		6,482,070
Accumulated deficit		(6,669,541)		(6,513,176)
Total Stockholders’ Equity (Deficit)		(153,717)		2,648
Total Liabilities and Stockholders' Equity (Deficit)	$	506,392	$	604,406

		June 30, 2016		December 31, 2016
ASSETS
Current Assets
Cash	$	3,251	$	11,460
Accounts receivable, trade, net		2,468		12,046
Inventory		12,023		25,810
Prepaid expenses		10,089		4,851
Other current assets		400		400
Total current assets		28,231		54,567
Property and equipment, net		501,886		549,839
Total Assets	$	530,117	$	604,406
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current Liabilities
Accounts payable	$	226,457	$	222,773
Short-term debt		6,760		2,176
Accrued liabilities		75,278		69,477
Accounts payable – related parties		276,178		307,332
Related party debt - short-term		60,583		-
Total current liabilities		645,256		601,758
Total Liabilities		645,256		601,758
Capital stock $0.001 par value; 200,000,000 shares authorized
Class A – 31,774,332 shares issued and outstanding, respectively		31,774		31,774
Convertible Class B – 1,980,000 shares issued and outstanding		1,980		1,980
Additional paid in capital		6,482,070		6,482,070
Accumulated deficit		(6,630,963)		(6,513,176)
Total Stockholders’ Equity (Deficit)		(115,139)		2,648
Total Liabilities and Stockholders' Equity (Deficit)	$	530,117	$	604,406

The accompanying notes are an integral part of these unaudited consolidated financial statements.

Table of Contents

INCOMING, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three months ended June 30, 2017	Three months ended June 30, 2016	Six months ended June 30, 2017	Six months ended June 30, 2016
	Three months ended September 30, 2017	Three months ended September 30, 2016	Nine months ended September 30, 2017	Nine months ended September 30, 2016
Revenue	$~~2,904~~-	$~~46,195~~658	$6,380	$4647,~~819~~477
Revenue from related parties	-	2474,~~360~~585	64,655	2498,~~360~~945
Total Revenue	~~2,904~~-	7075,~~555~~243	71,035	71146,~~179~~422
Cost of revenue	1913,~~499~~428	73110,~~970~~782	~~118~~132,~~763~~191	84195,~~806~~588
Depreciation	1615,~~803~~850	1819,~~903~~024	3349,~~682~~532	3756,~~966~~990
Gross loss	(3329,~~398~~278)	(2254,~~318~~563)	(81110,~~410~~688)	(51106,~~593~~156)
Selling, General, and Administrative Expenses	1910,~~228~~659	2146,~~650~~265	3647,~~421~~080	4187,~~023~~289
Loss from Operations	(5239,~~626~~937)	(43100,~~968~~828)	(~~117~~157,~~831~~768)	(92193,~~616~~445)
Other income (expense)
Grant and other income	471,464	57558	~~202~~1,666	~~162~~720
Interest expense	(70105)	(~~206~~147)	(~~158~~263)	(~~377~~524)
Total other income (expense)	~~(23)~~1,359	~~(149)~~411	441,403	~~(215)~~196
Net Loss	$(5238,~~649~~578)	$(44100,~~117~~417)	$(~~117~~156,~~787~~365)	$(92193,~~831~~249)
Net Loss per Class A Common Share (Basic and Diluted)	$(0.00)	$(0.00)	$(0.00)	$(0.0001)
Net Loss per Class B Common Share (Basic and Diluted)	$(0.0302)	$(0.0205)	$(0.0608)	$(0.0510)
Weighted Average Number of Class A Common Shares Outstanding (Basic and Diluted)	31,774,332	31,774,332	31,774,332	31,774,332
Weighted Average Number of Class B Common Shares Outstanding (Basic and Diluted)	1,980,000	1,980,000	1,980,000	1,980,000

The accompanying notes are an integral part of these unaudited consolidated financial statements.

Table of Contents

INCOMING, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

		Six months ended June 30, 2017		Six months ended June 30, 2016
		Nine months ended September 30, 2017		Nine months ended September 30, 2016
Cash Flows from operating Activities
Net loss	$	(~~117~~156,~~787~~365)	$	(92193,~~831~~249)
Adjustments to reconcile net loss to net cash provided by operations:
Depreciation		3349,~~682~~532		3756,~~966~~990
Changes in operating assets and liabilities
Accounts receivable		911,~~578~~818		2228
Accounts receivable – related party		-		~~467~~57,205
Prepaid expenses		36,~~212~~346		48,~~108~~091
Inventory		13,787		~~(10~~3,~~056)~~253
Accounts payable		39,~~684~~111		46,~~678~~601
Accrued expenses		5,~~801~~869		277
Net cash used in operating activities		(4859,~~043~~902)		(5560,~~369~~804)
Cash flows from investing activities
Proceeds from sale of equipment		14,271		-
Net cash provided by investing activities		14,271		-
Cash flows from financing activities
Proceeds from related party debt		29,429		-
Proceeds from loan from employee		4,000		-
Payments on short-term debt		(3,866)		(5,691)
Payments on loan from employee		(4,000)		-
Net cash provided by (used in) financing activities		25,563		(5,691)
Proceeds from related party debt		42,394		-
Net cash (decrease) for period		(8,209)		(61,060)
Payments on short-term debt		(7,473)		(9,298)
Net cash provided by (used in) financing activities		34,921		(9,298)
Net cash (decrease) for period		(10,710)		(70,102)
Cash at beginning of period		11,460		71,496
Cash at end of period	$	~~3,251~~750	$	101,~~436~~394
Supplemental disclosure of cash flow information
Cash paid for interest	$	~~158~~263	$	~~377~~524
Cash paid for income taxes	$	-	$	226
Non-cash financing transactions
Prepaid expense financed with notes payable	$	8,450	$	11,794
Prepaid insurance financed with notes payable	$	8,450	$	11,794
Accounts payable - related party reclassified to notes payable - related party		31,154		-
Accounts payable - related party converted to notes payable - related party	$	31,154	$	-

The accompanying notes are an integral part of these unaudited consolidated financial statements.

Table of Contents

INCOMING, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1Basis of Presentation, Organization, and Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited consolidated financial statements of Incoming, Inc., a Nevada corporation, have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial information and, therefore, do not include all disclosures normally required by generally accounting principles accepted in the United States of America. These statements should be read in conjunction with the Company's most recent annual financial statements for the year ended December 31, 2016 included in our Annual Report on Form 10-K filed with the SEC on April 11, 2017. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying unaudited financial statements for the period ended ~~June~~September 30, 2017 are not necessarily indicative of the operating results that may be expected for the full year ending December 31, 2017.

Organization

Incoming, Inc. (“we” or the “Company”) was incorporated on December 22, 2006 in Nevada. Through our wholly-owned subsidiary North American Bio-Energies LLC (“NABE”), we operate in the alternative energy industry in the development and acquisition of commercial grade biodiesel facilities and the distribution and marketing of petroleum and biofuel products. In addition to operating as NABE, our subsidiary also does business as Foothills Bio-Energies, LLC (“Foothills”).

Note 2Going Concern

These financial statements have been prepared on a going concern basis. As of ~~June~~September 30, 2017, the Company had a working capital deficiency of $~~617~~639,~~025~~753, and had an accumulated deficit of $6,~~630~~669,~~963~~541. Its ability to continue as a going concern is dependent upon the ability of the Company to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The outcome of these matters cannot be predicted with any certainty at this time. These factors raise substantial doubt that the Company will be able to continue as a going concern. The Company to date has funded its initial operations through the issuance of capital stock and common stock options, loans from related parties, and revenue generated in the normal course of business. Management plans to continue to provide for its capital needs by the issuance of common stock and related party advances. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.

Table of Contents

Note 3Related Party Transactions

NABE sells a portion of its finished goods to Echols Oil Company, a company owned by our CEO, R. Samuel Bell, Jr. During the ~~six~~nine months ended ~~June~~September 30, 2017, the Company had sales to the related company totaling $64,655. As of ~~June~~September 30, 2017, the Company had no outstanding receivables from the related party company. As of ~~June~~September 30, 2017, the Company had outstanding notes payable to Echols totaling $6073,~~583~~548, and had $~~274~~276,~~916~~178 in related party payables to Echols and to Green Valley Bio-Fuels. Payables to Echols resulted from purchasing $1,262 in diesel exhaust fluid and from accepting loans from the related party. Of the $6073,~~583~~548 in total payables to Echols, $31,154 represents a ~~re-classification~~conversion from related party accounts payable to related party ~~notes~~note payable and additional borrowings during the nine months ended September 30, 2017 of $42,394. There are no formal agreements for the notes payable to Echols. Payables to Green Valley Bio-Fuels totaling $274,916 resulted from purchasing off-spec biodiesel for re-work in prior years. Green Valley Bio-Fuels is considered a related party since it is majority-owned by Mr. Frank A. Gay, who sits on the Company’s Board of Directors. During the nine months ended September 30, 2017, the Company also received, and subsequently repaid, an employee loan totaling $4,000.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

THE FOLLOWING DISCUSSION OF THE RESULTS OF OUR OPERATIONS AND FINANCIAL CONDITION SHOULD BE READ IN CONJUNCTION WITH OUR FINANCIAL STATEMENTS AND THE NOTES THERETO INCLUDED ELSEWHERE IN THIS REPORT.

This section of the report includes a number of forward-looking statements that reflect the Company’s current views with respect to future events and financial performance. Forward-looking statements are often identified by words like: "believe," "expect," "estimate," "anticipate," "intend," "project" and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements, which apply only as of the date of this annual report. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or our predictions.

The following discussion provides an analysis of the results of our operations, an overview of our liquidity and capital resources and other items related to our business. The following discussion and analysis should be read in conjunction with our unaudited consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and our audited financial statements and notes included in our Annual Report on Form 10-K as of and for the year ended December 31, 2016.

Overview

Company references herein are referring to consolidated information pertaining to Incoming, Inc., the registrant.

The following discussion is an overview of the important factors that management focuses on in evaluating our businesses, financial condition and operating performance and should be read in conjunction with the financial statements included in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward looking statements as a result of any number of ~~factors, including those set forth in this Quarterly Report and elsewhere in the Company’s Annual Report on Form 10-K and other public filings.~~

Table of Contents

factors, including those set forth in this Quarterly Report and elsewhere in the Company’s Annual Report on Form 10-K and other public filings.

All written and oral forward-looking statements made in connection with this Quarterly Report on Form 10-Q that are attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Given the uncertainties that surround such statements, you are cautioned not to place undue reliance on such forward-looking statements.

Company Overview

NABE is a refiner and producer of commercial-grade biodiesel as specified by the American Society of Testing and Materials (ASTM D6751). Our refining and production facility is located in Lenoir, North Carolina with a nameplate annual capacity of five million gallons. Our facility produces biodiesel from virgin, agri-based feedstock using commercial specifications. The biodiesel we produce is sold throughout North Carolina, South Carolina and Virginia directly or through wholesale distributors. Currently, we are engaged in producing biodiesel and strategically purchasing biodiesel from other producers to meet commercial requirements. We also purify and sell glycerin, which is created as a byproduct of the biodiesel production process. Once the facility has accumulated sufficient glycerin to make full loads, it is typically sold to the market.

Our production process starts with purchasing the most cost effective and suitable agri-based feedstock (e.g., soy, canola, sunflower, cotton seed and chicken/pork fat). A sample of every feedstock is tested by our in-house laboratory in order to develop the proper recipe of catalysts for the transesterification process. The glycerin byproduct is then separated from the biodiesel and any excess methanol is recovered. Recovered methanol is either sold or reused in the production process. Glycerin is sold on the open market as either a crude product or as a further-processed tech grade product. While biodiesel is our main product, glycerin is a popular chemical used in pharmaceutical and hygiene applications and serves as an additional source of revenue.

Our facility is capable of producing biodiesel from a wide range of agri-based feedstocks: soy, canola, sunflower, cotton seed and chicken/pork fat. Biodiesel production costs are highly dependent on the cost of feedstock, and we believe the ability to utilize a variety of feedstocks efficiently and interchangeably is imperative to gaining a competitive advantage in the biodiesel production market.

Results of Operations

The following is a discussion and analysis of our results of operations for the three and ~~six~~nine-month periods ended ~~June~~September 30, 2017 and 2016, and the factors that could affect our future financial condition. This discussion and analysis should be read in conjunction with our financial statements and the notes thereto included elsewhere in this report. Our financial statements are prepared in accordance with United States generally accepted accounting principles. All references to dollar amounts in this section are in United States dollars unless expressly stated otherwise.

Revenue and Revenue From Related Parties

The Company generated ~~revenues~~no ofrevenue ~~$2,904~~ during the period ~~April~~July 1, 2017 through ~~June~~September 30, 2017.

The Company generated revenues of $75,243 during the period July 1, 2016 through September 30, 2016. Revenue generated during the period was ~~solely~~ due to sales of ~~diluted~~biodiesel, ~~methanol~~RINs, and materials recovered during glycerin purification processing. During the period July 1, 2016 through September 30, 2016, our biodiesel sales to third parties. totaled approximately $42 and our sales to related parties amounted to

The Company generated revenues of $70,555 during the period April 1, 2016 through June 30, 2016.

Revenue generated during the period was due to sales of biodiesel, RINs, and materials recovered during glycerin purification processing. During the period April 1, 2016 through June 30, 2016, our biodiesel sales to third parties totaled approximately $2,536 and our sales to related parties amounted to $24,630. RIN sales transacted during the second quarter of 2016 totaled $43,043. During the glycerin purification process, acid is added to the crude glycerin. As a result, high fatty acid oil separates from the glycerin and

yields high fatty acid oil and recovered methanol. Sales of the recovered methanol sales were $616 for the period under consideration.

Comparing the Company’s activity for the period April 1, 2017 through June 30, 2017 to the activity for the period April 1, 2016 through June 30, 2016, there was a decrease in revenue of $67,651 from $70,555 to $2,904. The period-over-period decrease was primarily due to inactivity at the biodiesel production in Lenoir, NC during the second quarter. Depressed benchmark (petroleum) prices, high raw material costs and expiration of the blender tax credit have severely hampered the biodiesel market.

The Company generated revenues of $71,035 during the period January 1, 2017 through June 30, 2017. Revenue generated during the period was due to sales of biodiesel, kerosene, de-methylated glycerin, and recovered methanol. Third-party transactions during the first two quarters of 2017 included biodiesel sales totaling $43, diluted methanol sales of $2,904 de-methylated glycerin sales of $2,775, and recovered methanol sales of $658. Related party kerosene sales totaled $64,655 during the period under consideration.

The Company generated revenues of $71,179 during the period January 1, 2016 through June 30, 2016. Revenue generated during the period was due to sales of biodiesel, RINs, and materials recovered during glycerin purification processing. Our third party biodiesel sales totaled $2,573 in the first half of 2016. We had biodiesel sales to related parties totaling $24,360 during the period under consideration. RIN sales transacted during the first half of 2016 totaled $43,043. Recovered methanol sales were $1,203 for the period January 1, 2016 through June 30, 2016.

Comparing the Company’s activity for the period January 1, 2017 through June 30, 2017 to the activity for the period January 1, 2016 through June 30, 2016, there was a decrease in revenue of $144 from $71,179 to $71,035. The period-over-period decrease was minimal; however, the activity was different for the separate periods. In the six months ended June 30, 2017, revenue was primarily attributable to $64,655 in related party kerosene sales. There were kerosene sales during the same period in 2016. The largest revenue contributor during the first six months of 2016 was $43,043 in RIN sales. There were no RIN sales during the same period in 2017. Third party biodiesel sales totaled $2,573 in the first six months of 2016, but only amounted to $43 for the same period in 2017. Also impacting comparative revenues were sales of glycerin, and recovered methanol. The Company had glycerin sales of $2,775 during the first half of 2017, but had no glycerin sales during the same period in 2016. The Company recognized $1,203 in recovered methanol sales during the first half of 2016 and had $2,904 in recovered methanol sales during the same period in 2017.

Cost of Revenue

Cost of revenue totaled $19,499 during the period April 1, 2017 through June 30, 2017. For the same period, cost of revenue consisted of costs associated with raw material sales, labor, overhead, and utilities.

Cost of revenue totaled $73,970 during the period April 1, 2016 through June 30, 2016. For the same period, cost of revenue consisted of costs associated with raw material (feedstocks, methanol, and catalyst) purchases, labor, overhead, and utilities.

Comparing the Company’s activity for the period April 1, 2017 through June 30, 2017 to the activity for the period April 1, 2016 through June 30, 2016, there was a decrease in cost of revenues of $54,471 from $73,970 to $19,499. The period-over-period decrease was in line with reduced production activity and also affected by operating with a leaner production crew at the biodiesel facility in Lenoir, NC.

~~Cost~~Table of revenue totaled $118,763 during the period January 1, 2017 through June 30, 2017. For the same period, cost of revenue consisted of costs associated with kerosene purchases, labor, overhead, and utilities.Contents

~~Cost~~$74,585. ofRINs ~~revenue~~were ~~totaled~~transferred ~~$84,806~~to the related party for all such sales transacted during the ~~period~~third ~~January~~quarter 1,of 2016. ~~through~~During ~~June~~the 30glycerin purification process, ~~2016.~~acid ~~For~~is added to the ~~same~~crude ~~period~~glycerin. As a result, ~~cost~~high offatty ~~revenue~~acid ~~consisted~~oil ofseparates ~~costs~~from ~~associated~~the ~~with~~glycerin ~~raw~~and ~~material~~yields ~~(feedstocks,~~high ~~methanol,~~fatty acid oil and ~~catalyst)~~recovered ~~purchases,~~methanol. Sales ~~labor,~~of ~~overhead,~~the ~~and~~recovered ~~utilities~~methanol sales were $616 for the period under consideration.

Comparing the Company’s activity for the period ~~January~~July 1, 2017 through ~~June~~September 30, 2017 to the activity for the period ~~January~~July 1, 2016 through ~~June~~September 30, 2016, there was ana ~~increase~~decrease in ~~cost~~revenue of ~~revenues of~~ $3375,~~957~~243 ~~from~~as ~~$84,806~~the toCompany ~~$118,763~~generated no revenue during the current quarter. The period-over-period ~~increase~~decrease was primarily due to ~~operating~~inactivity ~~with a leaner production crew~~ at the biodiesel production ~~facility~~ in Lenoir, NC~~. During~~ ~~the~~during ~~first half of 2016,~~ the ~~Company~~third ~~recognized~~quarter. Depressed anbenchmark ~~offset~~(petroleum) toprices, ~~the~~high ~~cost~~raw ofmaterial ~~goods~~costs ~~sold~~and ~~totaling~~expiration ~~$48,994 as a result~~ of ~~filing for~~ the blender tax credit ~~associated~~have ~~with~~severely ~~blended~~hampered ~~gallons. The Company did not recognize and blender tax credits during~~ the ~~same~~biodiesel ~~period in the current year~~market. Further impacting the year-over-year increase was the newly implemented strategy for selling kerosene during the current year. Kerosene cost of sales totaled $46,895 during the first six months of 2017 while there were no such transactions during the same period in 2016.

The Company generated revenues of $71,035 during the period January 1, 2017 through September 30, 2017. Revenue generated during the period was due to sales of biodiesel, kerosene, de-methylated glycerin, and recovered methanol. Third-party transactions during the first three quarters of 2017 included biodiesel sales totaling $43, diluted methanol sales of $2,904 de-methylated glycerin sales of $2,775, and recovered methanol sales of $658. Related party kerosene sales totaled $64,655 during the period under consideration.

The Company generated revenues of $146,422 during the period January 1, 2016 through September 30, 2016. Revenue generated during the period was due to sales of biodiesel, RINs, and materials recovered during glycerin purification processing. Our third party biodiesel sales totaled $2,615 in the first nine months of 2016. We had biodiesel sales to related parties totaling $98,945 during the period under consideration. RIN sales transacted to related parties during the first three quarters of 2016 totaled $43,043. Recovered methanol sales were $1,819 for the period January 1, 2016 through September 30, 2016.

Comparing the Company’s activity for the period January 1, 2017 through September 30, 2017 to the activity for the period January 1, 2016 through September 30, 2016, there was a decrease in revenue of $75,387 from $146,422 to $71,035. The period-over-period activities differed during the periods under consideration. In the nine months ended September 30, 2017, revenue was primarily attributable to $64,655 in related party kerosene sales. There were no kerosene sales during the same period in 2016. The largest revenue contributor during the first nine months of 2016 was $43,043 in RIN sales. There were no RIN sales during the same period in 2017. Third party biodiesel sales totaled $2,615 in the first nine months of 2016, but only amounted to $43 for the same period in 2017. Related party biodiesel sales totaled $98,495 during the first nine months of 2016 while there were no related party biodiesel sales during the same period in 2017. Also impacting comparative revenues were sales of glycerin, and recovered methanol. The Company had glycerin sales of $2,775 during the first nine months of 2017, but had no glycerin sales during the same period in 2016. The Company recognized $1,819 in recovered methanol sales during the first nine months of 2016 and had $658 in recovered methanol sales during the same period in 2017. Also during 2017, the Company had diluted methanol sales totaling $2,904 but did not have diluted methanol sales during 2016.

Cost of Revenue

Cost of revenue totaled $13,428 during the period July 1, 2017 through September 30, 2017. For the same period, cost of revenue consisted of costs associated with payroll, overhead, and utilities.

Cost of revenue totaled $110,782 during the period July 1, 2016 through September 30, 2016. For the same period, cost of revenue consisted of costs associated with raw material (feedstocks, methanol, and catalyst) purchases, labor, overhead, and utilities.

Table of Contents

Comparing the Company’s activity for the period July 1, 2017 through September 30, 2017 to the activity for the period July 1, 2016 through September 30, 2016, there was a decrease in cost of revenues of $97,354 from $110,782 to $13,428. The period-over-period decrease was in line with reduced production activity and also affected by operating with a leaner production crew at the biodiesel facility in Lenoir, NC.

Cost of revenue totaled $132,191 during the period January 1, 2017 through September 30, 2017. For the same period, cost of revenue consisted of costs associated with kerosene purchases, labor, overhead, and utilities.

Cost of revenue totaled $195,588 during the period January 1, 2016 through September 30, 2016. For the same period, cost of revenue consisted of costs associated with raw material (feedstocks, methanol, and catalyst) purchases, labor, overhead, and utilities.

Comparing the Company’s activity for the period January 1, 2017 through September 30, 2017 to the activity for the period January 1, 2016 through September 30, 2016, there was a decrease in cost of revenues of $63,397 from $195,588 to $132,191. The period-over-period decrease was due to operating with a leaner production crew at the biodiesel production facility in Lenoir, NC. During the first nine months of 2016, the Company recognized an offset to the cost of goods sold totaling $48,994 as a result of filing for the blender tax credit associated with blended gallons. The Company did not recognize and blender tax credits during the same period in the current year. Further impacting the year-over-year increase was the newly implemented strategy for selling kerosene during the current year. Kerosene cost of sales totaled $46,895 during the first nine months of 2017 while there were no such transactions during the same period in 2016.

Gross Loss

The Company had a gross loss of $3329,~~398~~278 for the period ~~April~~July 1, 2017 through ~~June~~September 30, 2017. The primary reason for the gross loss during the period was the Company’s inability to produce and sell biodiesel under adverse market conditions, including lower petroleum benchmark prices.

The Company had a gross loss of $2254,~~318~~563 for the period ~~April~~July 1, 2016 through ~~June~~September 30, 2016. The primary reason for the gross loss during the period was the Company’s inability to produce and sell biodiesel under adverse market conditions, including lower petroleum benchmark prices.

The Company had a gross loss of $81110,~~410~~688 for the period January 1, 2017 through ~~June~~September 30, 2017. The primary reason for the gross loss during the period was the Company’s inability to produce and sell biodiesel under adverse market conditions, including lower petroleum benchmark prices.

The Company had a gross loss of $51106,~~593~~156 for the period January 1, 2016 through ~~June~~September 30, 2016. The primary reason for the gross loss during the period was the Company’s inability to produce and sell biodiesel under adverse market conditions, including lower petroleum benchmark prices.

Selling, General and Administrative (SG&A) Expenses

SG&A expenses totaled $1910,~~228~~659 for the period ~~April~~July 1, 2017 through ~~June~~September 30, 2017. During the period under consideration, SG&A expenses primarily consisted of costs associated with payroll, office overhead and professional fees.

SG&A expenses totaled $2146,~~650~~265 for the period ~~April~~July 1, 2016 through ~~June~~September 30, 2016. During the period under consideration, SG&A expenses primarily consisted of costs associated with payroll, office overhead and professional fees.

Comparing the Company’s activity for the period April 1, 2017 through June 30, 2017 to the activity for the period April 1, 2016 through June 30, 2016, there was a decrease in SG&A expenses of $2,422 as SG&A decreased from $21,650 to $19,228. The period-over-period decrease was due primarily to reduced plant personnel at the biodiesel production facility in Lenoir, NC.11

10Table of Contents

~~SG&A~~Comparing ~~expenses~~the ~~totaled~~Company’s ~~$36,421~~activity for the period ~~January~~July 1, 2017 through ~~June~~September 30, 2017. ~~During~~to the activity for the period ~~under~~July ~~consideration~~1, 2016 through September 30, 2016, there was a decrease in SG&A expenses ~~primarily~~of ~~consisted~~$35,606 ofas ~~costs~~SG&A ~~associated~~decreased ~~with~~from ~~payroll~~$46,265 ~~office~~to ~~overhead~~$10,659. ~~and~~The ~~professional~~period-over-period ~~fees~~decrease was due primarily to reduced plant personnel at the biodiesel production facility in Lenoir, NC.

SG&A expenses totaled $4147,~~023~~080 for the period January 1, ~~2016~~2017 through ~~June~~September 30, ~~2016~~2017. During the period under consideration, SG&A expenses primarily consisted of costs associated with payroll, office overhead and professional fees.

~~Comparing~~SG&A ~~the~~expenses ~~Company’s~~totaled ~~activity~~$87,289 for the period January 1, ~~2017~~2016 through ~~June~~September 30, ~~2017~~2016. toDuring the ~~activity for the~~ period ~~January~~under 1consideration, ~~2016 through June 30, 2016, there was a decrease in~~ SG&A expenses ofprimarily ~~$4,602~~consisted asof ~~SG&A~~costs ~~declined~~associated ~~from $41,023 to $36,421. The slight period-over-period decrease is in line~~ with ~~reduced personnel at the biodiesel production facility in Lenoir~~payroll, ~~NC.~~office ~~Otherwise, general~~ overhead ~~remained~~and ~~stable~~professional ~~considering the first half of the current year compared with the first half of the prior year~~fees.

Comparing the Company’s activity for the period January 1, 2017 through September 30, 2017 to the activity for the period January 1, 2016 through September 30, 2016, there was a decrease in SG&A expenses of $40,209 as SG&A declined from $87,289 to $47,080. The period-over-period decrease is in line with reduced personnel at the biodiesel production facility in Lenoir, NC. Otherwise, general overhead remained stable considering the first half of the current year compared with the first half of the prior year.

Other Income (Expense)

Other Income totaled $471,464 during the period ~~April~~July 1, 2017 through ~~June~~September 30, 2017. During the ~~second~~third quarter of 2017, this amount was attributable to ~~funding~~a ~~received~~rebate from ~~the~~our ~~USDA~~insurance ~~Biofuel Program~~carrier. ~~Each~~The ~~quarter~~$1,464 ~~the~~of ~~Company~~Other ~~submits~~Income arecognized ~~Payment~~during ~~Request~~the ~~(Form~~current ~~RD-4288)~~quarter ~~and~~was ~~supporting~~related ~~documents~~ to ~~the~~a ~~USDA~~refund ~~delineating~~from ~~those~~our ~~gallons~~insurance ~~produced/sold~~carrier. ~~Along with the documentation, the Company informs the USDA regarding the type and quantity of feedstocks utilized.~~ ~~These~~Our ~~payment~~carrier ~~requests~~performed ~~are reviewed by~~ an ~~agent~~audit of ~~the~~2016 ~~USDA~~ and ~~then~~determined ~~submitted~~that aswe ~~part~~were ofeligible ~~the “pool”~~ for ~~funding.~~a ~~Biodiesel producers compete for whatever funding is available from the USDA’s pool~~refund. ~~Since~~The itrefund iswas ~~difficult~~recorded toin ~~predict~~Other ~~the~~Income, ~~amount~~instead of ~~funding~~an ~~that~~offset ~~may~~to beinsurance ~~received~~expense, ~~the~~since ~~Company~~its ~~only~~basis ~~recognizes~~was ~~Other~~an ~~Income~~audit ~~associated~~of ~~with~~a ~~the~~prior ~~USDA Biofuel Program when the funds are received.~~year

Other Income totaled $57558 during the period ~~April~~July 1, 2016 through ~~June~~September 30, 2016. During the ~~second~~third quarter of 2016, this amount was attributable to $34 in funding received from the USDA Biofuel Program and to a $524 rebate from our insurance carrier. Each quarter, the Company submits a Payment Request (Form RD-4288) and supporting documents to the USDA delineating those gallons produced/sold. Along with the documentation, the Company informs the USDA regarding the type and quantity of feedstocks utilized. These payment requests are reviewed by an agent of the USDA and then submitted as part of the “pool” for funding. Biodiesel producers compete for whatever funding is available from the USDA’s pool. Since it is difficult to predict the amount of funding that may be received, the Company only recognizes Other Income associated with the USDA Biofuel Program when the funds are received.

Other Income totaled $~~202~~1,666 during the period January 1, 2017 through ~~June~~September 30, 2017. During the first ~~six~~nine months of 2017, this amount was attributable to funding received from the USDA Biofuel Program and from $1,464 in rebates from our insurance carrier.

Other Income totaled $~~162~~720 during the period January 1, 2016 through ~~June~~September 30, 2016. During the first ~~six~~nine months of 2016, this amount was attributable to $196 in funding received from the USDA Biofuel Program and from $524 in rebates from our insurance carrier.

Liquidity and Capital Resources

Working Capital

		As of June 30, 2017		As of December 31, 2016
Current Assets	$	28,231	$	54,567
Current Liabilities	$	645,256	$	601,758
Working Capital Deficiency	$	(617,025)	$	(547,191)
Accumulated Deficit	$	(6,630,963)	$	(6,513,176)

11Table of Contents

		As of September 30, 2017		As of December 31, 2016
Current Assets	$	20,356	$	54,567
Current Liabilities	$	660,109	$	601,758
Working Capital Deficiency	$	(639,753)	$	(547,191)
Accumulated Deficit	$	(6,669,541)	$	(6,513,176)

Cash Flows

		Six Months Ended June 30, 2017		Six Months Ended June 30, 2016
		Nine Months Ended September 30, 2017		Nine Months Ended September 30, 2016
Cash used in operating activities	$	(4859,~~043~~902)	$	(5560,~~369~~804)
Cash provided by investing activities		14,271		-
Cash provided by (used in) financing activities		2534,~~563~~921		(59,~~691~~298)
Net (decrease) in cash	$	(810,~~209~~710)	$	(6170,~~060~~102)

As of ~~June~~September 30, 2017, our current assets totaling $2820,~~231~~356 consisted of cash, accounts receivable, inventory, other current assets and prepaid expenses. Our accounts payable and accrued liabilities and current portion of amounts due to related parties and third parties were $~~645~~660,~~256~~109 as of ~~June~~September 30, 2017. As a result, we had a working capital deficiency of $~~617~~639,~~025~~753.

Current assets for the Company totaled $54,567 as of December 31, 2016. Current liabilities for the Company totaled $601,758 as of December 31, 2016, which resulted in a working capital deficiency of $547,191.

Comparing the working capital deficiency at ~~June~~September 30, 2017 to the deficiency at December 31, 2016, there was an increase of $6992,~~834~~562 as the deficiency increased from $547,191 to $~~617~~639,~~025~~753. The biggest contributor to the overall increase in the deficit was operating in an environment of unfavorable market conditions – lower benchmark petroleum prices while feedstock prices have not reduced commensurately.

On a short-term basis, it is anticipated that the Company’s liquidity needs will be met through selling biodiesel related products and RIN-gallons, through borrowing from related parties and through the sale of common stock. Considering the long-term view, the Company intends to provide liquidity through operation of its biodiesel plant in Lenoir, North Carolina. Since the December 31, 2016 balance sheet date, total receivables have decreased $911,~~578~~818 with no amounts written off.

To date, cash flow requirements have been primarily met through sales of biodiesel related products and kerosene, through collections of accounts receivable, through share issuances, and through gross proceeds from bank and related party loans. For the ~~six~~nine months ended ~~June~~September 30, 2017, the Company generated a gross loss of $81110,~~410~~688 on sales of $71,035 over the same period. For the ~~six~~nine months ended June 30, 2016, the Company generated a gross loss of $51106,~~593~~156 on sales of $71146,~~179~~422 over the same period.

A portion of the Company’s operations have been funded through the issuance of common stock shares. As of ~~June~~September 30, 2017, the Company has issued 33,754,332 shares of common stock (31,774,332 shares of Class A stock and 1,980,000 shares of Class B stock).

To date, our cash flow requirements have been primarily met by equity financings and from operating the Company's biodiesel production facility in Lenoir, NC. Management expects to keep operational costs to a minimum until cash is available through financing or operating activities. Management plans to continue to seek other sources of financing on favorable terms; however, there are no assurances that any such financing can be obtained on favorable terms, if at all. Our ability to continue as a going concern is dependent upon the ability of the Company to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The outcome of these matters cannot be predicted with any certainty at this time. These factors raise substantial doubt that the Company will be able to continue as a going concern.

1213

Table of Contents

a minimum until cash is available through financing or operating activities. Management plans to continue to seek other sources of financing on favorable terms; however, there are no assurances that any such financing can be obtained on favorable terms, if at all. Our ability to continue as a going concern is dependent upon the ability of the Company to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The outcome of these matters cannot be predicted with any certainty at this time. These factors raise substantial doubt that the Company will be able to continue as a going concern.

Cash Used In Operating Activities

During the period January 1, 2017 through ~~June~~September 30, 2017, the Company’s cash used in operating activities totaled $4859,~~043~~902. For the same period, the Company’s cash used in operating activities was primarily attributable to collecting trade receivables ~~associated with kerosene sales~~, and to making transactions on trade payables. Third party trade receivables decreased $911,~~578~~818 while inventories decreased $13,787. Third party trade payables and accrued expenses increased $39,~~684~~111 and $5,~~801~~869, respectively, for the same period. Related party payables decreased $31,154 due to a ~~reclassification~~conversion of trade payables to notes payable (see Cash Provided By Financing Activities below). Depreciation expense was $3349,~~682~~532 for the first ~~six~~nine months of 2017.

During the period January 1, 2016 through ~~June~~September 30, 2016, the Company’s cash used in operating activities totaled $5560,~~369~~804. For the same period, the Company’s cash ~~used~~provided inby operating activities was primarily attributable to generating trade receivables associated with biodiesel and RIN sales, and making payments on trade payables. Third party trade receivables decreased $2228 and related party receivables decreased $~~467~~57,205 while inventories ~~increased~~decreased $103,~~056~~253. Trade payables increased $46,~~678~~601 for the same period. Depreciation expense was $3756,~~966~~990 for the first ~~six~~nine months of 2016.

Cash Provided By Investing Activities

During the period January 1, 2017 through ~~June~~September, 2017, the Company’s cash flows provided by investing activities totaled $14,271. Cash provided by investing activity resulted from the sale of equipment comprising the diesel exhaust fluid (DEF) production system. The equipment was sold to a third party at book value, therefore, no gain or loss was recorded on the sale.

During the period January 1, 2016 through ~~June~~September, 2016, the Company had no cash flows related to investing activities.

Cash Provided By Financing Activities

During the period January 1, 2017 through ~~June~~September 30, 2017, the Company’s cash flow related to financing activities totaled $2534,~~563~~921. This amount represents proceeds provided from short-term financing from a related party and employee loan during the period under consideration. At December 31, 2016, the Company recognized a related party payable totaling $31,154. This amount was ~~reclassified~~converted asto a note payable during the current year.

During the period January 1, 2016 through ~~June~~September 30, 2016, the Company’s cash flow related to financing activities totaled $59,~~691~~298. This amount represents funds paid for short-term debt during the current period.

Table of Contents

Future Financings

We anticipate that additional funding will be required in the form of equity financing from the sale of our common stock in order to proceed with our acquisition and expansion plan. However, we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock to fund our marketing and acquisition plans. At this time, we do not have any arrangements in place for any future equity financing.

Off-Balance Sheet Arrangements

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

Recent Accounting Pronouncements

Management does not expect any financial statement impact from any recently-issued pronouncements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

ITEM 4. CONTROLS AND PROCEDURES

(a)Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, we conducted an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (“CEO”) of our disclosure controls and procedures (as defined in Rules13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, the CEO concluded that our disclosure controls and procedures were not effective as of ~~June~~September 30, 2017. We have identified the following material weaknesses in our internal control over financial reporting:

Lack of Independent Board of Directors and Audit Committee

Management is aware that an audit committee composed of the requisite number of independent members along with a qualified financial expert has not yet been established. Considering the costs associated with procuring and providing the infrastructure to support an independent audit committee and the limited number of transactions, management has concluded that the risks associated with the lack of an independent audit committee are not sufficient to justify the creation of such a committee at this time. Management will periodically reevaluate this situation.

Deficiencies in Our Control Environment.

Our control environment did not sufficiently promote effective internal control over financial reporting throughout the organization. This material weakness exists because of the aggregate effect of multiple deficiencies in internal control which affect our control environment, including: a) the lack of an effective risk assessment process for the identification of fraud risks; b) the lack of an internal audit function or other effective mechanism for ongoing monitoring of the effectiveness of internal controls; c) deficiencies ~~in our accounting system and controls; d) and insufficient documentation and communication of our accounting policies and procedures as of June 30, 2017.~~

Table of Contents

in our accounting system and controls; d) and insufficient documentation and communication of our accounting policies and procedures as of September 30, 2017.

Deficiencies in the staffing of our financial accounting department.

The number of qualified accounting personnel with experience in public company SEC reporting and GAAP is limited. This weakness does not enable us to maintain adequate controls over our financial accounting and reporting processes regarding the accounting for non-routine and non-systematic transactions. There is a risk that a material misstatement of the financial statements could be caused, or at least not be detected in a timely manner, by this shortage of qualified resources.

Deficiencies in Segregation of Duties.

The limited number of qualified accounting personnel results in an inability to have independent review and approval of financial accounting entries. Furthermore, management and financial accounting personnel have wide-spread access to create and post entries in our financial accounting system. There is a risk that a material misstatement of the financial statements could be caused, or at least not be detected in a timely manner, due to insufficient segregation of duties.

Because of its inherent limitation, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Our financial accounting staff is actively attending and receiving training. Management is still determining additional measures to remediate deficiencies related to staffing.

(b)Changes in Internal Controls Over Financial Reporting

There were no changes that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

In the Court of Common Pleas of the State of South Carolina’s Thirteenth Judicial Circuit (Greenville County), a Plaintiff has filed suit against the Company and its subsidiary, NABE. The filing took place in June of 2015. In its filing, the Plaintiff claims to be a subsidiary of a foreign biodiesel producer with which NABE transacted import activities during 2013 and 2014. The Plaintiff further claims that the Company did not have the right to retain the $510,030 that was received and recognized as Other Income during the second quarter of 2015. An agreement signed with a customer in 2014 allowed the Company to retain and recognize this income, which was dependent upon reinstatement of the federal biodiesel blender tax credit. Subsequent to our agreement with the customer, the blender tax credit was retroactively reinstated. The Company recognized the Other Income when the customer, after having successfully filed for the credit, remitted payment to the Company. The Company believes that the Plaintiff's actions are unfounded and that there is remote likelihood of incurring any liability. The Company is vigorously defending the action.

ITEM 1A. RISK FACTORS

Table of Contents

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. OTHER INFORMATION

None.

ITEM 5. EXHIBITS

The following documents are filed as a part of this report or are incorporated by reference to previous filings, if so indicated:

Exhibit No.	Description

3.1	Articles of Incorporation (1)
3.2	Bylaws (1)
31.1	Section 302 Certification of CEO*
31.2	Section 302 Certification of Principal Financial Officer *
32.1	Section 906 Certification of CEO*
32.2	Section 906 Certification of Principal Financial Officer*

*filed herewith

(1) Incorporated by reference to the Form S-1 registration statement filed on June 30, 2008.

1617

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

~~August~~November 2114, 2017

By: ~~INCOMING, INC /s/ R. Samuel Bell, Jr. R. Samuel Bell, Jr., CEO and Chairman, Board of Directors /s/ Eric Norris Vice President, Finance (Principal Financial Officer)~~

17INCOMING, INC.

/s/ R. Samuel Bell, Jr.

R. Samuel Bell, Jr., CEO and Chairman, Board of Directors

/s/ Eric Norris

Vice President, Finance (Principal Financial Officer)

Filing Compare · Incoming, Inc.